Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004957031 | SCV005470196 | uncertain significance | Inborn genetic diseases | 2024-12-03 | criteria provided, single submitter | clinical testing | The c.4919A>G (p.E1640G) alteration is located in exon 37 (coding exon 36) of the PCDH15 gene. This alteration results from a A to G substitution at nucleotide position 4919, causing the glutamic acid (E) at amino acid position 1640 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |